The administration of a polyvalent mechanical bacterial lysate in elderly patients with COPD results in serological signs of an efficient immune response associated with a reduced number of acute episodes

Pulmonary Pharmacology and Therapeutics

Volumn 27, Issue 1, 2014, Pages 109-113

  Ricci, Rossella ^a   Palmero, Candida ^a   Bazurro, Gyada ^a   Riccio, Anna Maria ^b   Garelli, Valentina ^b   Di Marco, Eddi ^a   Cirillo, Carmelina ^a   Braido, Fulvio ^b   Canonica, Giorgio Walter ^b   Melioli, Giovanni ^a  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Antibodies; Chronic obstructive pulmonary disease; Immune response; Polyvalent mechanical bacterial lysate; Respiratory tract infections

Indexed keywords

ANTIBODY; BACTERIUM LYSATE; DIPHTHERIA ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; POLYVALENT MECHANICAL BACTERIAL LYSATE; TETANUS TOXOID; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACTERIUM DETECTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; FEMALE; HIGH RISK PATIENT; HUMAN; IMMUNE RESPONSE; INFLUENZA VACCINATION; INNATE IMMUNITY; MALE; MULTICENTER STUDY; MYCOPLASMA PNEUMONIAE; NOSE SMEAR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SEROCONVERSION; SEROLOGY; THROAT CULTURE; VERY ELDERLY; VIRUS DETECTION;

ANTIBODIES; CHRONIC OBSTRUCTIVE PULMONARY DISEASE; IMMUNE RESPONSE; POLYVALENT MECHANICAL BACTERIAL LYSATE; RESPIRATORY TRACT INFECTIONS;

ADAPTIVE IMMUNITY; ADJUVANTS, IMMUNOLOGIC; AGED; AGED, 80 AND OVER; ANTIBODIES; CELL EXTRACTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNITY, INNATE; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TREATMENT OUTCOME;

EID: 84892443572     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2013.05.006     Document Type: Article

References (17)

1. Villa E., Garelli V., Braido F., Melioli G., Canonica G.W. May we strengthen the human natural defenses with bacterial lysatesα. World Allergy Organ J 2010 Aug, 3(8 Suppl.):S17-S23.
2. Braido F., Tarantini F., Ghiglione V., Melioli G., Canonica G.W. Bacterial lysate in the prevention of acute exacerbation of COPD and in respiratory recurrent infections. Int J Chron Obstruct Pulmon Dis 2007, 2(3):335-345.
3. Cazzola M., Anapurapu S., Page C.P. Polyvalent mechanical bacterial lysate for the prevention of recurrent respiratory infections: a meta-analysis. Pulm Pharmacol Ther 2012 Feb, 25(1):62-68. [Epub 2011 Nov 27]. 10.1016/j.pupt.2011.11.002.
4. Morandi B., Agazzi A., D'Agostino A., Antonini F., Costa G., Sabatini F., et al. A mixture of bacterial mechanical lysates is more efficient than single strain lysate and of bacterial-derived soluble products for the induction of an activating phenotype in human dendritic cells. Immunol Lett 2011 Jul, 138(1):86-91. [Epub 2011 Mar 29].
5. Ferlazzo G., Tsang M.L., Moretta L., Melioli G., Steinman R.M., Münz C. Human dendritic cells activate resting natural killer (NK) cells and are recognized via theNKp30 receptor by activated NK cells. J Exp Med 2002, 195:343-351.
6. Steinman R.M., Hawiger D., Nussenzweig M.C. Tolerogenic dendritic cells. Annu Rev Immunol 2003, 21:685-711. 2.
7. Rossi G.A., Peri C., Raynal M.E., Defilippi A.C., Risso F.M., Schenone G., et al. Naturally occurring immune response against bacteria commonly involved in upper respiratory tract infections: analysis of the antigen-specific salivary IgA levels. Immunol Lett 2003 Mar 3, 86(1):85-91.
8. Braido F., Schenone G., Pallestrini E., Reggiardo G., Cangemi G., Canonica G.W., et al. The relationship between mucosal immunoresponse and clinical outcome in patients with recurrent upper respiratory tract infections treated with a mechanical bacterial lysate. J Biol Regul Homeost Agents 2011 Jul-Sep, 25(3):477-485.
9. Lanzilli G., Falchetti R., Tricarico M., Ungheri D., Fuggetta M.P. In vitro effects of an immunostimulating bacterial lysate on human lymphocyte function. Int J Immunopathol Pharmacol 2005 Apr-Jun, 18(2):245-254.
10. Lanzilli G., Falchetti R., Cottarelli A., Macchi A., Ungheri D., Fuggetta M.P. In vivo effect of an immunostimulating bacterial lysate on human B lymphocytes. Int J Immunopathol Pharmacol 2006 Jul-Sep, 19(3):551-559.
11. Lanzilli G., Traggiai E., Braido F., Garelli V., Folli C., Chiappori A., et al. Administration of a polyvalent mechanical bacterial lysate to elderly patients with COPD: effects on circulating T, B and NK cells. Immunol Lett 2013 Jan, 149(1-2):62-67.
12. Celli B.R., MacNee W. ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004 Jun, 23(6):932-946.
13. Bellamy D., Bouchard J., Henrichsen S., Johansson G., Langhammer A., Reid J., et al. International Primary Care Respiratory Group (IPCRG) guidelines: management of chronic obstructive pulmonary disease (COPD). Prim Care Respir J 2006 Feb, 15(1):48-57.
14. Di Marco E., Cangemi G., Filippetti M., Melioli G., Biassoni R. Development and clinical validation of a real-time PCR using a uni-molecular scorpion-based probe for the detection of Mycoplasma pneumoniae in clinical isolates. New Microbiol 2007 Oct, 30(4):415-421.
15. Defilippi A., Silvestri M., Tacchella A., Giacchino R., Melioli G., Di Marco E., et al. Epidemiology and clinical features of Mycoplasma pneumoniae infection in children. Respir Med 2008 Dec, 102(12):1762-1768.
16. Oxford J.S., Al-Jabri A.A., Lambkin R., Palache A.M., Fleming D.M. Non-responders to egg grown influenza vaccine seroconvert after booster immunization with MDCK cell grown vaccine. Vaccine 2003 Jun 20, 21(21-22):2743-2746.
17. Walsh E.E. Respiratory syncytial virus infection in adults. Semin Respir Crit Care Med 2011 Aug, 32(4):423-432.